DescriptionPhilip Morris International Inc. is a leading international tobacco company. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products (`RRPs`). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements.
Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 101.58 +1.93% increase |
| 110.27 -6.10% decrease |
| -5.98 (-5.46%) decrease |
|3-Month|| 101.58 +1.93% increase |
| 119.43 -13.30% decrease |
| -12.69 (-10.92%) decrease |
|52-Week|| 86.78 +19.31% increase |
| 123.55 -16.20% decrease |
| +13.54 (+15.04%) increase |